248
Views
52
CrossRef citations to date
0
Altmetric
Drug Profile

Decitabine in the treatment of myelodysplastic syndromes

, , , &
Pages 9-22 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Beatrice Balboni, Btissame El Hassouni, Richard J. Honeywell, Dzjemma Sarkisjan, Elisa Giovannetti, Julie Poore, Callie Heaton, Christine Peterson, Ely Benaim, Young B. Lee, Deog J. Kim & Godefridus J. Peters. (2019) RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment. Expert Opinion on Investigational Drugs 28:4, pages 311-322.
Read now
Yu Jing, Xue Shen, Qian Mei & Weidong Han. (2015) Spotlight on decitabine for myelodysplastic syndromes in Chinese patients. OncoTargets and Therapy 8, pages 2783-2790.
Read now
Andrey Poleshko, Andrew V Kossenkov, Natalia Shalginskikh, Anna Pecherskaya, Anna Pecherskaya, Margret B Einarson, Margret B Einarson, Anna Marie Skalka, Anna Marie Skalka, Richard A Katz & Richard A Katz. (2014) Human factors and pathways essential for mediating epigenetic gene silencing. Epigenetics 9:9, pages 1280-1289.
Read now
Braxton D Mitchell & Elizabeth A Streeten. (2013) Clinical impact of recent genetic discoveries in osteoporosis. The Application of Clinical Genetics 6, pages 75-85.
Read now

Articles from other publishers (48)

Hui Liu, Hao Jiang, Hongyan Tong, Ruixiang Xia, Linhua Yang, Hongguo Zhao, Jian Ouyang, Hai Bai, Hui Sun, Li Hou, Ming Jiang, Yun Zeng, Zhuogang Liu, Aibin Liang, Yinghua Xie, Kang Yu, Zhimin Zhai, Li Liu, Jinsong Jia, Rong Fu & Zonghong Shao. (2023) Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial. Cancer Medicine 12:13, pages 13885-13893.
Crossref
Ailin Zhao, Hui Zhou, Jinrong Yang, Meng Li & Ting Niu. (2023) Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, Carolina Nör, Barbara Kunzler Souza, Lauro Gregianin, André Tesainer Brunetto & Rafael Roesler. (2023) Targeting the epigenome of cancer stem cells in pediatric nervous system tumors. Molecular and Cellular Biochemistry.
Crossref
John P. Brabson, Tiffany Leesang, Sofia Mohammad & Luisa Cimmino. (2021) Epigenetic Regulation of Genomic Stability by Vitamin C. Frontiers in Genetics 12.
Crossref
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance & William C. Phelps. (2020) Blueprint for cancer research: Critical gaps and opportunities. CA: A Cancer Journal for Clinicians 71:2, pages 107-139.
Crossref
Aleksandra Kosianova, Vladlena Tiasto, Margarita Yatsunskaya, Yuri Khotimchenko & Alexander Kagansky. (2020) Natural molecules as modulators of epigenetic silencing in human cells for cancer care and aging. Biological Communications 65:4.
Crossref
Kaiji Zhang, Ying Lian, Xiaohong Guan, Qian Hu, Lihua Lei, Li Tao, Dong He, Juan Lin, Zheng Hou, Lirong Ren, Xiaoxiao Liu, Qian Ren, Lin Pan, Xiaoli Fei, Mei Xiong, Shunzhu Wen & Jinzhu Cao. (2020) Very-low-dose decitabine treatment for patients with intermediate- or high-risk myelodysplastic syndrome: a retrospective analysis of thirteen cases. Annals of Hematology 99:11, pages 2539-2546.
Crossref
Ling Chen, Shuang Liu & Yongguang Tao. (2020) Regulating tumor suppressor genes: post-translational modifications. Signal Transduction and Targeted Therapy 5:1.
Crossref
Christopher Butler, Samuel Sprowls, Gabor Szalai, Tasneem Arsiwala, Pushkar Saralkar, Benjamin Straight, Shea Hatcher, Evan Tyree, Michael Yost, William J. Kohler, Benjamin Wolff, Emily Putnam, Paul Lockman & Tuoen Liu. (2020) Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene. Translational Oncology 13:6, pages 100775.
Crossref
Emma Scaletti, Magnus Claesson, Thomas Helleday, Ann-Sofie Jemth & Pål Stenmark. (2020) The First Structure of an Active Mammalian dCTPase and its Complexes With Substrate Analogs and Products. Journal of Molecular Biology 432:4, pages 1126-1142.
Crossref
Taylor Lee Chong, Emily L. Ahearn & Luisa Cimmino. (2019) Reprogramming the Epigenome With Vitamin C. Frontiers in Cell and Developmental Biology 7.
Crossref
Jong Woo Park & Jeung-Whan Han. (2019) Targeting epigenetics for cancer therapy. Archives of Pharmacal Research 42:2, pages 159-170.
Crossref
Chengyu Deng, Lynette Naler & Chang Lu. (2019) Microfluidic epigenomic mapping technologies for precision medicine. Lab on a Chip.
Crossref
Takanori Fukunaga, Yuki Fujita, Haruhiko Kishima & Toshihide Yamashita. (2018) Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma. PLOS ONE 13:11, pages e0206552.
Crossref
Bo Yang, Ruili Yu, Lili Cai, Xiaohua Chi, Cui Liu, Lei Yang, Xueyan Wang, Peifeng He & Xuechun Lu. (2017) A comparison of therapeutic dosages of decitabine in treating myelodysplastic syndrome: a meta-analysis. Annals of Hematology 96:11, pages 1811-1823.
Crossref
Kim-Hien T. Dao. (2017) Myelodysplastic Syndromes. Medical Clinics of North America 101:2, pages 333-350.
Crossref
Costantine Albany, Mary P. Hever-Jardine, Katherine M. von Herrmann, Christina Y. Yim, Janice Tam, Joshua M. Warzecha, Leah Shin, Sarah E. Bock, Brian S. Curran, Aneeq S. Chaudhry, Fred Kim, George E. Sandusky, Pietro Taverna, Sarah J. Freemantle, Brock C. Christensen, Lawrence H. Einhorn & Michael J. Spinella. (2016) Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine. Oncotarget 8:2, pages 2949-2959.
Crossref
Chunchao Zhang, Jinfeng Suo, Hiroyuki Katayama, Yue Wei, Guillermo Garcia-Manero & Samir Hanash. (2016) Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines. Clinical Proteomics 13:1.
Crossref
Cristina E. Requena, Guiomar Pérez-Moreno, András Horváth, Beáta G. Vértessy, Luis M. Ruiz-Pérez, Dolores González-Pacanowska & Antonio E. Vidal. (2016) The nucleotidohydrolases DCTPP1 and dUTPase are involved in the cellular response to decitabine. Biochemical Journal 473:17, pages 2635-2643.
Crossref
QINGXIAO HONG, YIRUN LI, XIAOYING CHEN, HUADAN YE, LINLIN TANG, ANNAN ZHOU, YAN HU, YUTING GAO, RONGRONG CHEN, YONGMING XIA & SHIWEI DUAN. (2016) CDKN2B, SLC19A3 and DLEC1 promoter methylation alterations in the bone marrow of patients with acute myeloid leukemia during chemotherapy. Experimental and Therapeutic Medicine 11:5, pages 1901-1907.
Crossref
Kathrin Bauer, Franz Hutzschenreuter, Nicole Skoetz, Karl-Anton Kreuzer, Ina Monsef & Andreas Engert. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Huiyuan Kang, Xinrong Wang, Li Gao, Jian Cen, Mianyang Li, Wei Wang, Nan Wang, Yonghui Li, Lili Wang & Li Yu. (2015) Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome. European Journal of Medical Research 20:1.
Crossref
Seunghoon Han, Yoo-Jin Kim, Jongtae Lee, Sangil Jeon, Taegon Hong, Gab-jin Park, Jae-Ho Yoon, Seung-Ah Yahng, Seung-Hwan Shin, Sung-Eun Lee, Ki-Seong Eom, Hee-Je Kim, Chang-Ki Min, Seok Lee & Dong-Seok Yim. (2015) Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome. Journal of Hematology & Oncology 8:1.
Crossref
Yongxing Zhang, Chao Ma, Xuqiang Liu, Zhenkai Wu, Peng Yan, Nan Ma, Qiming Fan & Qinghua Zhao. (2015) Epigenetic landscape in PPARγ2 in the enhancement of adipogenesis of mouse osteoporotic bone marrow stromal cell. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852:11, pages 2504-2516.
Crossref
Yong-Xing Zhang, Hai-Lang Sun, He Liang, Kai Li, Qi-Ming Fan & Qing-Hua Zhao. (2015) Dynamic and distinct histone modifications of osteogenic genes during osteogenic differentiation. Journal of Biochemistry, pages mvv059.
Crossref
Hongli Li, Yan Wang, Wenwei Xu, Lin Dong, Yan Guo, Kehong Bi & Chuansheng Zhu. (2015) Arsenic Trioxide Inhibits DNA Methyltransferase and Restores TMS1 Gene Expression in K562 Cells. Acta Haematologica 133:1, pages 18-25.
Crossref
Yinguo Bai, Na Fang, Tingxun Gu, Yuhua Kang, Jiang Wu, Desheng Yang, Hui Zhang, Zhimin Suo & Shaoping Ji. (2014) HOXA11 gene is hypermethylation and aberrant expression in gastric cancer. Cancer Cell International 14:1.
Crossref
Piyanuch Sripayap, Tadashi Nagai, Mitsuyo Uesawa, Hiroyuki Kobayashi, Tomonori Tsukahara, Ken Ohmine, Kazuo Muroi & Keiya Ozawa. (2014) Mechanisms of resistance to azacitidine in human leukemia cell lines. Experimental Hematology 42:4, pages 294-306.e2.
Crossref
Jiaojiao Ma, Liu Hong, Zheng Chen, Yongzhan Nie & Daiming Fan. (2013) Epigenetic Regulation of microRNAs in Gastric Cancer. Digestive Diseases and Sciences 59:4, pages 716-723.
Crossref
Christopher J Ricketts, Mark R Morris, Dean Gentle, Salwati Shuib, Michael Brown, Noel Clarke, Wenbin Wei, Paul Nathan, Farida Latif & Eamonn R Maher. (2013) Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma. Clinical Epigenetics 5:1.
Crossref
Godefridus J. Peters, Kees Smid, Leonardo Vecchi, Ietje Kathmann, Dzjemma Sarkisjan, Richard J. Honeywell, Nienke Losekoot, Osnat Ohne, Aric Orbach, Eran Blaugrund, Lak Shin Jeong, Young Bok Lee, Chang-Ho Ahn & Deog Joong Kim. (2013) Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360). Investigational New Drugs 31:6, pages 1444-1457.
Crossref
Hady Ghanem, A. Megan Cornelison, Guillermo Garcia-Manero, Hagop Kantarjian, Farhad Ravandi, Tapan Kadia, Jorge Cortes, Susan O'Brien, Mark Brandt, Gautam Borthakur & Elias Jabbour. (2013) Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome. Clinical Lymphoma Myeloma and Leukemia 13, pages S289-S294.
Crossref
Sebastian Rogenhofer, Herdis Miersch, Friederike Göke, Philip Kahl, Wolf F. Wieland, Ferdinand Hofstädter, Glen Kristiansen, Alexander von Ruecker, Stefan C. Müller & Jörg Ellinger. (2013) Histone Methylation Defines an Epigenetic Entity in Penile Squamous Cell Carcinoma. The Journal of Urology 189:3, pages 1117-1122.
Crossref
Torben Redmer, Dirk Schumacher, Wasco Wruck, Reinhold Schäfer & Christian R. A. Regenbrecht. 2013. Stem Cells: Current Challenges and New Directions. Stem Cells: Current Challenges and New Directions 199 224 .
Yujuan Yang, Qingxia Zhang, Feng Xu, Chunkang Chang & Xiao Li. (2012) Aberrant promoter methylation of D ab2 gene in myelodysplastic syndrome . European Journal of Haematology 89:6, pages 469-477.
Crossref
Ho Kang. (2012) Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation. International Journal of Oncology.
Crossref
Yujuan Yang, Qingxia Zhang, Feng Xu, Lingyun Wu, Qi He & Xiao Li. (2012) Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome. Journal of Cancer Research and Clinical Oncology 138:5, pages 729-737.
Crossref
Sunit Kumar Singh & Praveensingh B. Hajeri. 2012. Molecular and Cellular Therapeutics. Molecular and Cellular Therapeutics 140 167 .
John R Bracht, David H Perlman & Laura F Landweber. (2012) Cytosine methylation and hydroxymethylation mark DNA for elimination in Oxytricha trifallax. Genome Biology 13:10, pages R99.
Crossref
Christian Arsov, Wolfgang Goering & Wolfgang A. Schulz. 2012. Patho-Epigenetics of Disease. Patho-Epigenetics of Disease 123 157 .
Sang-Hyun Song, Sae-Won Han & Yung-Jue Bang. (2011) Epigenetic-Based Therapies in Cancer. Drugs 71:18, pages 2391-2403.
Crossref
Ines Zidi & Nidhal Ben Amor. (2011) HLA-G regulators in cancer medicine: an outline of key requirements. Tumor Biology 32:6, pages 1071-1086.
Crossref
Min‐Yu Chen, Warren S.‐L. Liao, Zhen Lu, William G. Bornmann, Violeta Hennessey, Michele N. Washington, Gary L. Rosner, Yinhua Yu, Ahmed Ashour Ahmed & Robert C. BastJr.Jr.. (2011) Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer 117:19, pages 4424-4438.
Crossref
Kathrin Bauer, Nicole Skoetz, Ina Monsef, Andreas Engert & Corinne Brillant. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David M Thomas. (2011) Lessons from the deep study of rare tumours. The Journal of Pathology 224:3, pages 306-308.
Crossref
Brock C. Christensen, Ashley A. Smith, Shichun Zheng, Devin C. Koestler, E. Andres Houseman, Carmen J. Marsit, Joseph L. Wiemels, Heather H. Nelson, Margaret R. Karagas, Margaret R. Wrensch, Karl T. Kelsey & John K. Wiencke. (2011) DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma. JNCI: Journal of the National Cancer Institute 103:2, pages 143-153.
Crossref
Sonja Eberth, Björn Schneider, Andreas Rosenwald, Elena M Hartmann, Julia Romani, Margarete Zaborski, Reiner Siebert, Hans G Drexler & Hilmar Quentmeier. (2010) Epigenetic regulation of CD44in Hodgkin and non-Hodgkin lymphoma. BMC Cancer 10:1.
Crossref
Kanjaksha Ghosh & Kinjalka Ghosh. (2010) Advances in Haematological Pharmacotherapy in 21st Century. Indian Journal of Hematology and Blood Transfusion 26:2, pages 30-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.